IRD
Opus Genetics, Inc.
NASDAQ: IRD · HEALTHCARE · BIOTECHNOLOGY
$4.99
-6.90% today
Updated 2026-05-08
Market cap
$356.30M
P/E ratio
—
P/S ratio
25.10x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$1 – $6
Volume
0.9M
Opus Genetics, Inc. (IRD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-296.30%
ROE
-242.40%
ROA
-55.40%
Debt/equity
0.18x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-6.17M | — | — | — |
| 2020 | $0.00 | $-24.62M | — | — | — |
| 2021 | $589000.00 | $-56.69M | 100.00% | -3,854.84% | -9,625.30% |
| 2022 | $39.85M | $17.89M | 100.00% | 45.74% | 44.89% |
| 2023 | $19.05M | $-9.99M | 100.00% | -55.45% | -52.42% |
| 2024 | $10.99M | $-57.53M | 100.00% | -564.72% | -523.40% |
| 2025 | $14.20M | $-49.59M | 99.63% | -271.90% | -349.33% |